By Health News Canada KIRKLAND, QC, May 9 /CNW Telbec/ – A real-world study evaluating the safety of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine] among 189,629 females in California found no serious adverse events related to vaccination, no safety signals for any health event resulting in an emergency room […]
Firm sponsors Gardasil film documenting harmful side effects
Jere Beasley Report May 3, 2011 Our firm has committed financially to help a group of independent filmmakers in the creation of a documentary that would shed light on the harmful side effects of the HPV vaccine, Gardasil. Titled “One More Girl,” the documentary will share the stories of individuals and families devastated following a […]
No Cancer Vaccine for Boys
By Andrew M. Potts The Pharmaceutical Benefits Advisory Committee (PBAC) has rejected a submission to add the human papillomavirus (HPV) vaccine Gardasil to the Pharmaceutical Benefits Scheme (PBS) for use in males. Gardasil is currently only available on the PBS for girls through the National Immunisation Program (NIP) to combat cervical cancer. Last year, drug […]
Gardasil debate renewed
By Aaron Derfel, Gazette Health Reporter Critics doubt benefits for women up to age 45. MONTREAL – Health Canada’s decision to approve the Gardasil vaccine for women up to the age of 45 has renewed the debate about the purported benefits of the shots and whether they might even be necessary. Kirkland-based Merck, maker of […]
Merck, Qiagen launch Rwandan cervical cancer deal
By Kate Kelland, Health and Science Correspondent * Merck to donate 2 million doses of Gardasil HPV vaccine * Qiagen to give 250,000 tests for women aged 35-45 * Rwanda to pay “dramatically” cut price after first 3 years LONDON, April 25 (Reuters) – U.S. drugmaker Merck and German diagnostics firm Qiagen are donating millions […]
- « Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 57
- Next Page »
